With the skyrocketing popularity of GLP-1 RAs, some lesser-known side effects, including anemia, are coming to light.

The House Ways and Means Health Subcommittee on Tuesday held a hearing to consider proposals to revise the Medicare reimbursement system for anemia medications administered to kidney dialysis patients ...

CMS on Monday announced a proposal to limit Medicare reimbursements for the treatment of cancer patients with anemia medications manufactured by Amgen and Johnson & Johnson, the Wall Street Journal ...

The U.S. Food and Drug Administration announced the approval of the first hematopoietic stem cell transplant therapy to treat ...

Data from nearly 3000 patients across multiple countries with the disease showed that undertreatment was most notable among patient with hemoglobin (Hb) <10 g/dL. Researchers have taken a look at the ...

Vitamin B12 deficiency can be caused by poor diet or malabsorption, leading to fatigue, muscle weakness, and memory problems.

Treatment with intravenous (IV) iron significantly improved survival and increased hemoglobin levels in patients with ...

Control of anemia in children on dialysis varies by region around the globe. Poor response to anemia medications is linked with inflammation, fluid retention, and hyperparathyroidism. Anemia and the ...

Amgen Inc. said Thursday that European regulators had proposed special warnings and reduced dosing recommendations for the use of anemia drugs, including its top-selling Aranesp. The new prescribing ...

Amgen Inc. swung to a profit in the third quarter on sharply higher sales of its anemia drugs, the biotechnology giant said Tuesday. Amgen’s revenue gain came at the expense of rival Johnson & Johnson ...

The display and use of drug information on this site is subject to express terms of use. By continuing to view the drug information, you agree to abide by such terms ...